Page 6 - Fsd Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FSD Pharma Inc wins FDA and Health Canada approval for IND for Phase 2 Trial of FSD201 for treating inflammatory disorder

FSD Pharma Inc wins FDA and Health Canada approval for IND for Phase 2 Trial of FSD201 for treating inflammatory disorder
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Lakshmi kotraWorld health organizationDrug administrationHealth canadaFsd pharma incInvestigational new drugIdiopathic mast cell activation syndromeLucid psycheceuticals

FSD Pharma Inc : FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On Novel Formulations of Palmitoylethanolamide, Presents Preclinical Toxicology Results at an International Symposium

FSD Pharma Inc : FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On Novel Formulations of Palmitoylethanolamide, Presents Preclinical Toxicology Results at an International Symposium
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Zeeshan saeedLakshmip kotraLucid psycheceuticals incDrug administrationFsd pharma incExchange commissionBiosciences incSymposium of the international cannabinoid research societyScientific affairsHealth canadaPharma incLucid psycheceuticalsInvestigational new drugAnnual symposiumInternational cannabinoid research societyAndrzej chruscinski

FSD Pharma Closes CAD$16 4 Million Sale of Non-Core Assets

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesZeeshan saeedAnthony durkaczExchange commissionBiosciences incLucid psycheceuticals incPharma incMuscular sclerosisDepression disordersCo executive chairmanLucid psycheceuticalsCanadian securities administratorsExecutive co chairmanBusiness wireFsd pharma inc

Insider Buying: FSD Pharma Inc (CNSX:HUGE) Director Acquires 50,000 Shares of Stock

FSD Pharma Inc (CNSX:HUGE – Get Rating) Director Anthony John Durkacz acquired 50,000 shares of FSD Pharma stock in a transaction dated Monday, April 25th. The stock was bought at an average price of $1.25 per share, for a total transaction of $62,500.00. Following the completion of the transaction, the director now directly owns 273,597 […]

Anthony john durkaczCentury financial capital group incScicann therapeutics incPharma incFsd pharma incFv pharma incGet ratingDirector anthony john durkaczMedical purposesScicann therapeutics inc theFsd pharmaCnsx hugeComputer and technologyInsider tradingNsider trades

FSD Pharma Inc (CNSX:HUGE) Director Zeeshan Saeed Buys 8,584 Shares

FSD Pharma Inc (CNSX:HUGE – Get Rating) Director Zeeshan Saeed purchased 8,584 shares of the company’s stock in a transaction on Thursday, April 21st. The shares were bought at an average cost of $1.40 per share, with a total value of $12,017.60. Following the transaction, the director now directly owns 477,360 shares of the company’s […]

Zeeshan saeedCentury financial capital group incScicann therapeutics incPharma company profile get ratingPharma incFsd pharma incFv pharma incGet ratingDirector zeeshan saeedCompany profileMedical purposesScicann therapeutics inc theFsd pharmaCnsx hugeComputer and technologyInsider trading